Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
SNDX · NASDAQ · Pharmaceutical Preparations
$8.72−0.41 (−4.49%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Syndax Pharmaceuticals (SNDX) · oqro.io/stocks/SNDX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Oct 29, 2026 · Filed Oct 30, 2026
Director sold ~$114K of SNDX shares in the open marketSourcePlanned sale · Planned for Oct 29, 2026 · Notice filed Oct 29, 2026
Director filed to sell about $115K of SNDX stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in SNDX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Hood River Capital Management LLC disclosed an increased position in SNDX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deerfield Management Company, L.P. disclosed a new position in SNDX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a new position in SNDX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Eventide Asset Management, LLC no longer reported SNDX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Hood River Capital Management LLC disclosed an increased position in SNDX for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Hood River Capital Management LLC disclosed a new position in SNDX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Eventide Asset Management, LLC disclosed an increased position in SNDX for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Eventide Asset Management, LLC disclosed a reduced position in SNDX for Q3 2025SourceInsider trade · Traded Sep 8, 2025 · Filed Sep 8, 2025
CEO sold ~$2.58M of SNDX shares in the open marketSourceInsider trade · Traded Aug 18, 2025 · Filed Aug 18, 2025
Director sold ~$304K of SNDX shares in the open marketSourceInsider trade · Traded Aug 15, 2025 · Filed Aug 18, 2025
Director sold ~$298K of SNDX shares in the open marketSourceInsider trade · Traded Aug 14, 2025 · Filed Aug 18, 2025
Director sold ~$273K of SNDX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Eventide Asset Management, LLC disclosed an increased position in SNDX for Q2 2025SourceInsider trade · Traded Jul 16, 2025 · Filed Jul 18, 2025
CEO sold ~$70K of SNDX shares in the open marketSourceInsider trade · Traded Jul 16, 2025 · Filed Jul 18, 2025
CFO sold ~$12K of SNDX shares in the open marketSourceInsider trade · Traded May 16, 2025 · Filed May 19, 2025
Officer purchased ~$106K of SNDX shares in the open marketSourceInsider trade · Traded May 19, 2025 · Filed May 19, 2025
Director purchased ~$91K of SNDX shares in the open marketSourceInsider trade · Traded May 19, 2025 · Filed May 19, 2025
Director purchased ~$45K of SNDX shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Avoro Capital Advisors LLC no longer reported SNDX for Q1 2025SourceInsider trade · Traded Mar 4, 2025 · Filed Mar 6, 2025
CEO sold ~$118K of SNDX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Eventide Asset Management, LLC disclosed an increased position in SNDX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in SNDX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC no longer reported SNDX for Q4 2024SourceInsider trade · Traded Feb 10, 2025 · Filed Feb 12, 2025
CEO sold ~$206K of SNDX shares in the open marketFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Eventide Asset Management, LLC disclosed a new position in SNDX for Q3 2024SourceInsider trade · Traded Feb 10, 2025 · Filed Feb 12, 2025
CFO sold ~$59K of SNDX shares in the open marketSourceInsider trade · Traded Feb 10, 2025 · Filed Feb 12, 2025
Officer sold ~$72K of SNDX shares in the open marketSource